A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing
[post]
2022
unpublished
Genomic profiling of hematologic malignancies has augmented our understanding of variants that contribute to disease pathogenesis and supported development of prognostic models that inform disease management in the clinic. Tumor only sequencing assays are limited in their ability to identify definitive somatic variants, which can lead to ambiguity in clinical reporting and patient management. Here, we describe the MSK-IMPACT Heme cohort, a comprehensive data set of somatic alterations from
doi:10.21203/rs.3.rs-2094202/v1
fatcat:wmvlqehc2rhcbpjy3zv7bqbz7i